Eli Lilly and Company (NYSE:LLY) announced Monday that its Phase 3 BRUIN CLL-322 trial achieved its primary endpoint, demonstrating that the addition of Jaypirca (pirtobrutinib) to a standard regimen of venetoclax and rituximab significantly extended the time patients lived without their disease worsening.
Somnigroup International (NYSE:SGI) reached an agreement to acquire Leggett & Platt (NYSE:LEG) in an all-stock transaction valued at approximately $2.5 billion, a move that unites the world's largest bedding brand owner with its primary component supplier.
Fastenal (NASDAQ:FAST), a global leader in the wholesale distribution of industrial and construction supplies, reported its financial results for the first quarter ended March 31, 2026, today.
Vertiv Holdings (NYSE:VRT), a global provider of critical digital infrastructure and continuity solutions, announced on April 13, 2026, the acquisition of BMarko Structures.
Regeneron Pharmaceuticals (NASDAQ:REGN) and Telix Pharmaceuticals (NASDAQ:TLX) announced a landmark strategic collaboration on April 13, 2026, to co-develop and co-commercialize next-generation radiopharmaceutical therapies (RPTs).
Hillman Solutions (NASDAQ:HLMN), a leading provider of hardware products and merchandising solutions, announced on April 13, 2026, the acquisition of Delaney Hardware.
Allogene Therapeutics (NASDAQ:ALLO), a pioneer in allogeneic "off-the-shelf" CAR-T cell therapy, announced promising interim futility results today from its randomized Phase 2 ALPHA3 trial.
Regeneron Pharmaceuticals (NASDAQ:REGN) and Sanofi (NASDAQ:SNY) announced on April 13, 2026, that the European Commission, has expanded the marketing authorization for Dupixent (dupilumab) to include children aged 2 to 11 years with moderate-to-severe chronic spontaneous urticaria (CSU).
Baker Hughes (NASDAQ:BKR), a global leader in energy technology, announced on April 13, 2026, that it has reached a definitive agreement to sell its Waygate Technologies business to Hexagon, a Swedish-based leader in digital reality solutions.
AbbVie (NYSE:ABBV) and Haisco Pharmaceutical Group announced on April 10, 2026, a strategic licensing agreement to develop and commercialize a portfolio of novel pain compounds.
Borr Drilling (NYSE:BORR) issued a comprehensive operational update on April 13, 2026, announcing the return of four high-specification jack-up rigs to service in the Middle East.
ADS-TEC Energy (NASDAQ:ADSE), a global leader in battery-buffered ultra-fast charging technology, released its preliminary and unaudited financial statements for the fiscal year 2025 today.
-640x360.webp&w=3840&q=75)
